Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 31 min ago
PreprintAll rights reservedmedRxiv

More tests, higher scores: Testing frequency and SDMT differences between natalizumab and rituximab

  • T. P. Copeland1
  • S. Abdel Hay
  • F. Piehl
  • K. Fink
  • K. A. McKay
  1. 1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Read full textPDFDOICite

Related

  1. Faster peak alpha frequency precedes higher menstrual pain in adolescence
    Natalie R Osborne, Frank F Tu, Sarah E Darnell +2
    medRxivPreprintAll rights reservedFull textSurgery & anaesthesiamedRxivPMC
  2. Anti‐CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity (PIRA) in People With Multiple Sclerosis
    Leonardo Palazzo, Ferdinando Clarelli, Michele Surano +6
    European journal of neurologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Internet-use frequency, leisure-time exercise, and offline social interaction among older adults in China: rural–non-rural differences
    Zhengyuan Xu, Doheung Lee, Changliang Yan
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  4. Age-Related Differences in Corneal Higher-Order Aberrations Among School-Aged Children Referred After Vision Screening
    Fujimoto H, Tanaka T, Tanaka K +2
    Clinical OphthalmologyPeer-reviewedCC BYFull textGeneral medicineDOAJ
  5. Exploring the relationship between HIV Testing frequency and sexual behavior, prevention prophylaxis use among MSM in Southern China
    Yinxia Liang, Min Wang, Yun Zhang +9
    PLOS OnePeer-reviewedCC BY 4.0Full textMicrobiologyEpidemiology & public healthPLOS

Cite

BibTeXRIS
BibTeX
@misc{copeland2026more,
  title = {{More tests, higher scores: Testing frequency and SDMT differences between natalizumab and rituximab}},
  author = {T. P. Copeland and S. Abdel Hay and F. Piehl and K. Fink and K. A. McKay},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.21.26366102},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.21.26366102v1},
}
RIS
TY  - UNPB
TI  - More tests, higher scores: Testing frequency and SDMT differences between natalizumab and rituximab
AU  - T. P. Copeland
AU  - S. Abdel Hay
AU  - F. Piehl
AU  - K. Fink
AU  - K. A. McKay
PY  - 2026
DA  - 2026/10/21
PB  - medRxiv
DO  - 10.64898/2026.10.21.26366102
UR  - https://www.medrxiv.org/content/10.64898/2026.10.21.26366102v1
ER  -